Friday, August 29, 2008 - 3:08PM EST

Clinical Trials

1. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years.

Author
Konishi T; Watanabe T; Kishimoto J; Kotake K; Muto T; Nagawa H;
Institution
Department of Surgical Oncology, University of Tokyo, Tokyo, Japan.
Journal
Gut. 2007 Jun;56(6):863-8. Epub 2007 Jan 9.
Abstract URL
Click here to view abstract

2. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.

Author
Kulke MH; Stuart K; Enzinger PC; Ryan DP; Clark JW; Muzikansky A; Vincitore M; Michelini A; Fuchs CS;
Institution
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. matthew_kulke@dfci.harvard.edu
Journal
J Clin Oncol. 2006 Jan 20;24(3):401-6.
Abstract URL
Click here to view abstract

3. Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor.

Author
Bertoletti L; Elleuch R; Kaczmarek D; Jean-Francois R; Vergnon JM; Bertoletti L; Elleuch R; Kaczmarek D; Jean-Francois R; Vergnon JM;
Institution
Departments of Pulmonary Diseases and Thoracic Oncology, Hopital Nord, St. Etienne University Hospital, Saint-Etienne, 42000 Saint-Etienne, France. lbertoletti@free.fr
Journal
Chest. 2006 Nov;130(5):1405-11.
Abstract URL
Click here to view abstract

4. Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.

Author
Varker KA; Campbell J; Shah MH;
Institution
Division of Hematology-Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, A438 Starling-Loving Hall, 320 West 10th Avenue, Columbus, OH 43210, USA.
Journal
Cancer Chemother Pharmacol. 2008 Apr;61(4):661-8. Epub 2007 Jun 23.
Abstract URL
Click here to view abstract

5. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.

Author
Garcia-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Canizares MA; Muguruza I;
Institution
Thoracic Surgery Department of University Hospital, Valladolid, Spain. mgyuste2@wanadoo.es
Journal
Eur J Cardiothorac Surg. 2007 Feb;31(2):192-7. Epub 2006 Dec 29.
Abstract URL
Click here to view abstract

6. Clinical and in vitro studies of imatinib in advanced carcinoid tumors.

Author
Yao JC; Zhang JX; Rashid A; Yeung SC; Szklaruk J; Hess K; Xie K; Ellis L; Abbruzzese JL; Ajani JA;
Institution
Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. jyao@mdanderson.org
Journal
Clin Cancer Res. 2007 Jan 1;13(1):234-40.
Abstract URL
Click here to view abstract

7. Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.

Author
Yao JC; Phan A; Hoff PM; Chen HX; Charnsangavej C; Yeung SC; Hess K; Ng C; Abbruzzese JL; Ajani JA;
Institution
Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M.D. Anderson Cancer, 1515 Holcombe Blvd, Houston, TX 77030, USA. jyao@mdanderson.org
Journal
J Clin Oncol. 2008 Mar 10;26(8):1316-23.
Abstract URL
Click here to view abstract

8. Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.

Author
Kwekkeboom, Dik J; Teunissen, Jaap J; Bakker, Willem H; Kooij, Peter P; de Herder, Wouter W; Feelders, Richard A; van Eijck, Casper H; Esser, Jan-Paul; Kam, Boen L; Krenning, Eric P;
Institution
Department of Nuclear Medicine, Erasmus Medical Center, Dr Molewaterplein 40, 3015 GD Rotterdam, Netherlands. d.j.kwekkeboom@erasmusmc.nl
Journal
J Clin Oncol 2005 Apr 20;23(12):2754-62.
Abstract URL
Click here to view abstract

9. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors.

Author
Shah, Manisha H; Young, Donn; Kindler, Hedy L; Webb, Iain; Kleiber, Barbara; Wright, John; Grever, Michael;
Institution
Division of Hematology-Oncology, The Ohio State University, Columbus, Ohio 43210, USA. shah-2@medctr.osu.edu
Journal
Clin Cancer Res 2004 Sep 15;10(18 Pt 1):6111-8.
Abstract URL
Click here to view abstract

10. High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours.

Author
Welin, Staffan V; Janson, Eva Tiensuu; Sundin, Anders; Stridsberg, Mats; Lavenius, Erik; Granberg, Dan; Skogseid, Britt; Oberg, Kjell E; Eriksson, Barbro K;
Institution
Department of Medical Sciences, University Hospital, Uppsala, Sweden.
Journal
Eur J Endocrinol 2004 Jul;151(1):107-12.
Abstract URL
Click here to view abstract